Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
Journal of Neural Transmission
|
January 1, 1979
Behavioral and neuroendocrine effects of low dose ET-495: antagonism by haloperidol
B Angrist, M Ain, J Rotrosen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 11, 1991
Lack of efficacy of d-propranolol in neuroleptic-induced akathisia
L A Adler, B Angrist, P Fritz, et al.
Journal of Clinical Psychopharmacology
|
August 1, 1992
Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment
B Angrist, M d'Hollosy, M Sanfilipo, et al.
The American Journal of Psychiatry
|
August 1, 1978
Suppression of prolactin by dopamine agonists in schizophrenics and controls
J Rotrosen, B Angrist, C Clark, et al.
Psychopharmacology
|
January 1, 1987
Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophrenia
E Peselow, B Angrist, A Sudilovsky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 1, 1986
Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration
N D Volkow, J D Brodie, A P Wolf, et al.
Journal of Clinical Psychopharmacology
|
June 1, 1989
Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic children
K D Meiselas, E K Spencer, R Oberfield, et al.
The American Journal of Psychiatry
|
September 1, 1993
Vitamin E treatment of tardive dyskinesia
L A Adler, E Peselow, J Rotrosen, et al.
Biological Psychiatry
|
October 15, 1993
Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics
E Duncan, A Wolkin, B Angrist, et al.
Psychopharmacology Bulletin
|
January 1, 1984
Cholecystokinin octapeptide in dementia
M Serby, B Angrist, J Corwin, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
Journal of Neural Transmission
|
January 1, 1979
Behavioral and neuroendocrine effects of low dose ET-495: antagonism by haloperidol
B Angrist, M Ain, J Rotrosen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 11, 1991
Lack of efficacy of d-propranolol in neuroleptic-induced akathisia
L A Adler, B Angrist, P Fritz, et al.
Journal of Clinical Psychopharmacology
|
August 1, 1992
Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment
B Angrist, M d'Hollosy, M Sanfilipo, et al.
The American Journal of Psychiatry
|
August 1, 1978
Suppression of prolactin by dopamine agonists in schizophrenics and controls
J Rotrosen, B Angrist, C Clark, et al.
Psychopharmacology
|
January 1, 1987
Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophrenia
E Peselow, B Angrist, A Sudilovsky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 1, 1986
Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration
N D Volkow, J D Brodie, A P Wolf, et al.
Journal of Clinical Psychopharmacology
|
June 1, 1989
Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic children
K D Meiselas, E K Spencer, R Oberfield, et al.
The American Journal of Psychiatry
|
September 1, 1993
Vitamin E treatment of tardive dyskinesia
L A Adler, E Peselow, J Rotrosen, et al.
Biological Psychiatry
|
October 15, 1993
Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics
E Duncan, A Wolkin, B Angrist, et al.
Psychopharmacology Bulletin
|
January 1, 1984
Cholecystokinin octapeptide in dementia
M Serby, B Angrist, J Corwin, et al.
Page
of 10